Press release
AIDS- Related Kaposi's Sarcoma-Pipeline Insights, 2017
“AIDS - Related Kaposi's Sarcoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the AIDS - Related Kaposi's Sarcoma. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
Hurry up Limited Period Offer- We are Currently Offering Discount on this report: http://www.orbisresearch.com/contacts/discount/214567
(Discounted Price Details: Get Flat 15% on Single User License, Flat 25% on Site License & Flat 30% on Enterprise Licence)
Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for AIDS - Related Kaposi's Sarcoma. Report also assesses the AIDS - Related Kaposi's Sarcoma therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Browse Full Report with TOC: http://www.orbisresearch.com/reports/index/aids-related-kaposis-sarcoma-pipeline-insights-2017
Scope
• The report provides competitive pipeline landscape of AIDS- Related Kaposi’s Sarcoma
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the AIDS- Related Kaposi’s Sarcoma pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for AIDS- Related Kaposi’s Sarcoma and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Place Purchase Order for this Report@ http://www.orbisresearch.com/contact/purchase/214567
Table of Contents
AIDS - Related Kaposi's Sarcoma Overview
AIDS - Related Kaposi's Sarcoma Pipeline Therapeutics
AIDS - Related Kaposi's Sarcoma Therapeutics under Development by Companies
AIDS - Related Kaposi's Sarcoma Filed and Phase III Products
Comparative Analysis
AIDS - Related Kaposi's Sarcoma Phase II Products
Comparative Analysis
AIDS - Related Kaposi's Sarcoma Phase I and IND Filed Products
Comparative Analysis
AIDS - Related Kaposi's Sarcoma Discovery and Pre-Clinical Stage Products
Comparative Analysis
Drug Candidate Profiles
AIDS - Related Kaposi's Sarcoma – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
AIDS - Related Kaposi's Sarcoma – Discontinued Products
AIDS - Related Kaposi's Sarcoma – Dormant Products
Companies Involved in Therapeutics Development for AIDS - Related Kaposi's Sarcoma
Appendix
Methodology
Contact Us
Disclaimer
List of Tables:
Number of Products under Development for AIDS - Related Kaposi's Sarcoma, 2017
Number of Products under Development by Companies
Comparative Analysis by Filed and Phase III Products, 2017
Comparative Analysis Phase II Products, 2017
Comparative Analysis Phase I and IND Filed Products, 2017
Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
Drug Candidates Profiles
AIDS - Related Kaposi's Sarcoma Assessment by Monotherapy Products
AIDS - Related Kaposi's Sarcoma Assessment by Combination Products
AIDS - Related Kaposi's Sarcoma Assessment by Route of Administration
AIDS - Related Kaposi's Sarcoma Assessment by Stage and Route of Administration
AIDS - Related Kaposi's Sarcoma Assessment by Molecule Type
AIDS - Related Kaposi's Sarcoma Assessment by Stage and Molecule Type
AIDS - Related Kaposi's Sarcoma Therapeutics – Discontinued Products
AIDS - Related Kaposi's Sarcoma Therapeutics – Dormant Products
Products under Development by Companies, 2017
Number of Products under Development for AIDS - Related Kaposi's Sarcoma, 2017
Filed and Phase III Products, 2017
Phase II Products, 2017
Phase I and IND Filed Products, 2017
Discovery and Pre-Clinical Stage Products, 2017
AIDS - Related Kaposi's Sarcoma Assessment by Monotherapy Products
AIDS - Related Kaposi's Sarcoma Assessment by Combination Products
AIDS - Related Kaposi's Sarcoma Assessment by Route of Administration
AIDS - Related Kaposi's Sarcoma Assessment by Stage and Route of Administration
Orbis Research is a single point aid for all your Market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required Market research study for our clients.
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: sales@orbisresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AIDS- Related Kaposi's Sarcoma-Pipeline Insights, 2017 here
News-ID: 575041 • Views: …
More Releases from Orbis Research
Blood Purification Devices Market 2023-2028 | Top Players Baxter International, …
Based on the type segment, the portable equipment segment is expected to hold the largest share in Blood Purification Devices in the year 2028. Professionals that are actively involved in the ongoing purification of blood tend to favour portable equipment. Equipment that is portable enables effective emergency care. Additionally, portable equipment is rather space-efficient and compact, which promotes widespread use throughout the blood-purification process. In a manner similar to how…
Clean Beauty Market to Grow at 40.1% CAGR by 2028 - Key Players are Bare Mineral …
Clean beauty is described as beauty and personal care products that are made with the safest possible ingredients and have the lowest possible environmental impacts. Clean beauty pertains to products that are safe, non-toxic, and clearly labelled ingredients Also, the ingredients used are cruelty-free and are screened for non-GMO feedstock and residual pesticides.
Request a pdf brochure @ https://www.orbisresearch.com/contacts/request-sample/6941781
The Clean Beauty Market is valued at USD 5163.17 Million in 2021 and…
Outdoor Power Equipment Market Worth USD 6.49 Bn by 2027 - Industry Trends and S …
The outdoor power equipment generally includes, brush cutters, edger, chain saws, power rakes, and more. Outdoor power equipment is commonly used by end users, such as lawn & plant care providers and landscape service providers, for commercial purposes.
The global outdoor power equipment market in 2021 was valued at US$32.22 billion. The market value is projected to reach US$46.49 billion by 2027. Outdoor power equipment (OPE) is an equipment with small…
Merchant API Market to reach US$119.11 billion by 2027 - Industry Trends, Growth …
The latest research on "Global Merchant API Market: Analysis By Molecular Type, By Segment, By Type, By Type of Synthesis, By End-User, By Region Size And Trends With Impact Of COVID-19 And Forecast up to 2027" have been added to OrbisResearch.com store.
The merchant API market refers to the use of APIs by merchants, or businesses that sell goods and services, to connect their systems and processes with those of other…
More Releases for Sarcoma
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma…
Kaposi Sarcoma Market: High incidence of HIV/AIDS associated Kaposi sarcoma is o …
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market Analysis & Trends 2024
The global market for Kaposi sarcoma is projected to expand at a modest 2.2% CAGR from 2016 to 2024, with the opportunity in the market rising from US$118.5 mn in 2015 to be worth US$143.2 mn by the end of the forecast period. Hospitals formed the leading distribution channel in 2015, generating over US$40 mn revenue that year. The segment is also slated emerge as the fastest growing segment in…
Synovial Sarcoma - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Synovial Sarcoma - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Pipeline Review, H2 2017, provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape.
Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or…
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market: Patent Expiry of Blockbuster Drugs for Treatment of Kapos …
Kaposi sarcoma is a soft tissue sarcoma that develops in connective tissues, blood vessels, fibrous tissues, and muscles. It is a malignant, multi-centric, neoplastic vascular proliferation, characterized by the development of bluish-red cutaneous nodules on the feet. According to the U.S. Center for Disease Control and Prevention (CDC), Kaposi sarcoma is considered an acquired immune deficiency syndrome (AIDS) defining disease. This report analyzes the current and future prospects of the…
